VJHemOnc is committed to improving our service to you

EBMT 2020 | MRD testing for ALL in EBMT transplant centers

VJHemOnc is committed to improving our service to you

Arnon Nagler

Arnon Nagler, MD, MSc, Chaim Sheba Medical Center, Tel-Hashomer, Israel, discusses the results of the survey evaluating minimal residual disease (MRD) testing for acute lymphoblastic leukemia (ALL) in European Blood and Marrow Transplantation (EBMT) transplant centers. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter